3-bromopropyl cinnamate

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-bromopropyl cinnamate
• 英文别名: 3-bromopropyl (E)-3-phenylprop-2-enoate
• 化学式: C₁₂H₁₃BrO₂
• 分子量: 269.138
• InChiKey: KLDJZPPGSMMFOX-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-脱氧野尻霉素 、 3-bromopropyl cinnamate 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 以35%的产率得到
  参考文献：
  名称：

  作为潜在的α-葡萄糖苷酶抑制剂的新型N-烷基-脱氧野oji霉素衍生物的合成，体外抑制活性，动力学研究和分子对接

  摘要：

  摘要 一系列新颖的ñ -烷基-1-脱氧野尻霉素衍生物为25〜44，合成并评价了它们的体外α葡萄糖苷酶抑制活性，开发α葡萄糖苷酶具有高活性抑制剂。与标准阿卡波糖（IC 50 = 822.0±1.5 µM）相比，所有二十种化合物均表现出α-葡萄糖苷酶抑制活性，IC 50值为30.0±0.6 µM至2000 µM 。活性最高的化合物43比阿卡波糖高约27倍。动力学研究显示，化合物43，40，和34分别为在α葡糖苷所有竞争性抑制剂与ķ我 分别为10 µM，52 µM和150 µM。分子对接表明，高活性抑制剂通过四种相互作用与α-葡萄糖苷酶相互作用，包括氢键，π-π堆积相互作用，疏水相互作用和静电相互作用。在所有相互作用中，π-π堆积相互作用和氢键在化合物的各种活性中起重要作用。

  DOI：

  10.1080/14756366.2020.1826941
• 作为产物：
  描述：

  肉桂酸 、 3-溴-1-丙醇 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 7.0h， 生成 3-bromopropyl cinnamate
  参考文献：
  名称：

  Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity

  摘要：

  To develop novel and efficient heat shock protein 90-cell division cycle 37 (Hsp90-Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, 41 was screened with superior antiproliferative activity on related cancer cells (IC50: 0.41-0.94 mu M) and 41 could decrease the level of the Hsp90-Cdc37 complex in A549 cells. The capability to disrupt the Hsp90-Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that 41 might disrupt the interaction of the Hsp90-Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that 41 could significantly regulate the levels of Hsp90-Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, 41 is a novel Hsp90-Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hsp90-Cdc37 disruptors.

  DOI：

  10.1021/acs.jmedchem.9b01290

文献信息

• US5227444A
  申请人：——

  公开号：US5227444A

  公开（公告）日：1993-07-13
• Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity
  作者：Na Li、Manyi Xu、Bing Wang、Zhixian Shi、Zihao Zhao、Yunqing Tang、Xinyue Wang、Jianbo Sun、Li Chen

  DOI：10.1021/acs.jmedchem.9b01290

  日期：2019.12.12

  To develop novel and efficient heat shock protein 90-cell division cycle 37 (Hsp90-Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, 41 was screened with superior antiproliferative activity on related cancer cells (IC50: 0.41-0.94 mu M) and 41 could decrease the level of the Hsp90-Cdc37 complex in A549 cells. The capability to disrupt the Hsp90-Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that 41 might disrupt the interaction of the Hsp90-Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that 41 could significantly regulate the levels of Hsp90-Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, 41 is a novel Hsp90-Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hsp90-Cdc37 disruptors.
• Synthesis, <i>in vitro</i> inhibitory activity, kinetic study and molecular docking of novel <i>N</i>-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
  作者：Ping Lin、Jia-Cheng Zeng、Ji-Guang Chen、Xu-Liang Nie、En Yuan、Xiao-Qiang Wang、Da-Yong Peng、Zhong-Ping Yin

  DOI：10.1080/14756366.2020.1826941

  日期：2020.1.1

  evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC50 values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC50 = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds

  摘要 一系列新颖的ñ -烷基-1-脱氧野尻霉素衍生物为25〜44，合成并评价了它们的体外α葡萄糖苷酶抑制活性，开发α葡萄糖苷酶具有高活性抑制剂。与标准阿卡波糖（IC 50 = 822.0±1.5 µM）相比，所有二十种化合物均表现出α-葡萄糖苷酶抑制活性，IC 50值为30.0±0.6 µM至2000 µM 。活性最高的化合物43比阿卡波糖高约27倍。动力学研究显示，化合物43，40，和34分别为在α葡糖苷所有竞争性抑制剂与ķ我 分别为10 µM，52 µM和150 µM。分子对接表明，高活性抑制剂通过四种相互作用与α-葡萄糖苷酶相互作用，包括氢键，π-π堆积相互作用，疏水相互作用和静电相互作用。在所有相互作用中，π-π堆积相互作用和氢键在化合物的各种活性中起重要作用。